Bashkim Kadriu

3.6k total citations · 1 hit paper
59 papers, 2.6k citations indexed

About

Bashkim Kadriu is a scholar working on Biological Psychiatry, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bashkim Kadriu has authored 59 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Biological Psychiatry, 31 papers in Pharmacology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bashkim Kadriu's work include Tryptophan and brain disorders (32 papers), Treatment of Major Depression (29 papers) and Mental Health Research Topics (15 papers). Bashkim Kadriu is often cited by papers focused on Tryptophan and brain disorders (32 papers), Treatment of Major Depression (29 papers) and Mental Health Research Topics (15 papers). Bashkim Kadriu collaborates with scholars based in United States, Czechia and Italy. Bashkim Kadriu's co-authors include Carlos A. Zarate, Christoph Kraus, Alessandro Guidotti, Ioline D. Henter, Erminio Costa, John M. Davis, Siegfried Kasper, Rupert Lanzenberger, Marc S. Lener and Philip W. Gold and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Comparative Neurology and Biological Psychiatry.

In The Last Decade

Bashkim Kadriu

58 papers receiving 2.5k citations

Hit Papers

Prognosis and improved outcomes in major depression: a re... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bashkim Kadriu United States 30 1.0k 934 654 582 404 59 2.6k
Stefan Kloiber Germany 26 834 0.8× 677 0.7× 391 0.6× 387 0.7× 907 2.2× 96 2.9k
Chiara Fabbri Italy 31 900 0.9× 1.2k 1.2× 489 0.7× 499 0.9× 290 0.7× 155 3.1k
Teruhiko Higuchi Japan 32 755 0.7× 544 0.6× 525 0.8× 550 0.9× 534 1.3× 126 3.4k
Betina Elfving Denmark 35 1.0k 1.0× 527 0.6× 1.1k 1.7× 790 1.4× 732 1.8× 112 3.3k
Richard C. Shelton United States 31 1.1k 1.1× 1.5k 1.6× 818 1.3× 566 1.0× 444 1.1× 65 3.9k
Masaki Kato Japan 22 524 0.5× 815 0.9× 689 1.1× 506 0.9× 181 0.4× 123 2.5k
Fokko J. Bosker Netherlands 31 640 0.6× 466 0.5× 984 1.5× 608 1.0× 505 1.3× 82 2.6k
Irina Esterlis United States 30 816 0.8× 695 0.7× 1.0k 1.6× 761 1.3× 399 1.0× 101 3.0k
Manabu Fuchikami Japan 19 922 0.9× 617 0.7× 956 1.5× 632 1.1× 747 1.8× 29 2.4k
Sâmia Joca Brazil 36 988 1.0× 1.7k 1.8× 1.6k 2.5× 694 1.2× 829 2.1× 128 4.2k

Countries citing papers authored by Bashkim Kadriu

Since Specialization
Citations

This map shows the geographic impact of Bashkim Kadriu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bashkim Kadriu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bashkim Kadriu more than expected).

Fields of papers citing papers by Bashkim Kadriu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bashkim Kadriu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bashkim Kadriu. The network helps show where Bashkim Kadriu may publish in the future.

Co-authorship network of co-authors of Bashkim Kadriu

This figure shows the co-authorship network connecting the top 25 collaborators of Bashkim Kadriu. A scholar is included among the top collaborators of Bashkim Kadriu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bashkim Kadriu. Bashkim Kadriu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnston, Jenessa N., Peixiong Yuan, Bashkim Kadriu, et al.. (2025). Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study. Translational Psychiatry. 15(1). 524–524.
2.
Georgiou, Polymnia, Cristan Farmer, Gustavo C. Medeiros, et al.. (2024). Associations between hypothalamic-pituitary-adrenal (HPA) axis hormone levels, major depression features and antidepressant effects of ketamine. Journal of Affective Disorders. 373. 126–132. 5 indexed citations
3.
Johnston, Jenessa N., Ioline D. Henter, Christoph Kraus, et al.. (2023). Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile. Drug Discovery Today. 28(4). 103518–103518. 41 indexed citations
4.
Johnston, Jenessa N., Bashkim Kadriu, Josh Allen, et al.. (2023). Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment. Neuropharmacology. 226. 109422–109422. 39 indexed citations
5.
Kraus, Christoph, Alexander Kautzky, Bashkim Kadriu, et al.. (2023). Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database. Journal of Affective Disorders. 335. 349–357. 22 indexed citations
6.
Moaddel, Ruin, Panos Zanos, Cristan Farmer, et al.. (2022). Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration. Translational Psychiatry. 12(1). 179–179. 20 indexed citations
7.
Rabinowitz, Jonathan, Janet B. W. Williams, Ariana Anderson, et al.. (2022). Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D). Journal of Affective Disorders. 302. 273–279. 14 indexed citations
8.
Kadriu, Bashkim, et al.. (2022). Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics. Current topics in behavioral neurosciences. 56. 141–167. 5 indexed citations
9.
Farmer, Cristan, Jessica R. Gilbert, Ruin Moaddel, et al.. (2020). Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression. Neuropsychopharmacology. 45(8). 1398–1404. 65 indexed citations
10.
Kadriu, Bashkim, Cristan Farmer, Peixiong Yuan, et al.. (2019). The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response. Molecular Psychiatry. 26(8). 4085–4095. 66 indexed citations
11.
Kraus, Christoph, et al.. (2019). The influence of ketamine on drug discovery in depression. Drug Discovery Today. 24(10). 2033–2043. 52 indexed citations
12.
Moaddel, Ruin, Michelle Shardell, Mohammed Khadeer, et al.. (2018). Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects. Psychopharmacology. 235(10). 3017–3030. 62 indexed citations
13.
Kadriu, Bashkim, Shiwen Yuan, Cristan Farmer, et al.. (2018). Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability. Journal of Clinical Psychopharmacology. 38(3). 243–246. 3 indexed citations
14.
Ballard, Elizabeth D., Julia S. Yarrington, Cristan Farmer, et al.. (2018). Characterizing the course of suicidal ideation response to ketamine. Journal of Affective Disorders. 241. 86–93. 44 indexed citations
15.
Guo, Wei, Rodrigo Machado‐Vieira, Sanjay J. Mathew, et al.. (2018). Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Translational Psychiatry. 8(1). 108–108. 31 indexed citations
16.
Saligan, Leorey N., Cristan Farmer, Elizabeth D. Ballard, Bashkim Kadriu, & Carlos A. Zarate. (2018). Disentangling the association of depression on the anti-fatigue effects of ketamine. Journal of Affective Disorders. 244. 42–45. 13 indexed citations
17.
Kadriu, Bashkim, et al.. (2014). Pseudologia fantastica: Forensic and clinical treatment implications. Comprehensive Psychiatry. 56. 17–20. 4 indexed citations
18.
Maloku, Ekrem, Bashkim Kadriu, Adrian Zhubi, et al.. (2011). Selective α4β2 Nicotinic Acetylcholine Receptor Agonists Target Epigenetic Mechanisms in Cortical GABAergic Neurons. Neuropsychopharmacology. 36(7). 1366–1374. 32 indexed citations
19.
Auta, James, Francesco Impagnatiello, Bashkim Kadriu, Alessandro Guidotti, & Erminio Costa. (2008). Imidazenil: A low efficacy agonist at α1- but high efficacy at α5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology. 55(2). 148–153. 29 indexed citations
20.
Veldić, Marin, Bashkim Kadriu, Ekrem Maloku, et al.. (2007). Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophrenia Research. 91(1-3). 51–61. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026